Cargando…

Critical illness induces alternative activation of M2 macrophages in adipose tissue

INTRODUCTION: We recently reported macrophage accumulation in adipose tissue of critically ill patients. Classically activated macrophage accumulation in adipose tissue is a known feature of obesity, where it is linked with increasing insulin resistance. However, the characteristics of adipose tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Langouche, Lies, Marques, Mirna B, Ingels, Catherine, Gunst, Jan, Derde, Sarah, Vander Perre, Sarah, D'Hoore, André, Van den Berghe, Greet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334796/
https://www.ncbi.nlm.nih.gov/pubmed/22018099
http://dx.doi.org/10.1186/cc10503
_version_ 1782230688700825600
author Langouche, Lies
Marques, Mirna B
Ingels, Catherine
Gunst, Jan
Derde, Sarah
Vander Perre, Sarah
D'Hoore, André
Van den Berghe, Greet
author_facet Langouche, Lies
Marques, Mirna B
Ingels, Catherine
Gunst, Jan
Derde, Sarah
Vander Perre, Sarah
D'Hoore, André
Van den Berghe, Greet
author_sort Langouche, Lies
collection PubMed
description INTRODUCTION: We recently reported macrophage accumulation in adipose tissue of critically ill patients. Classically activated macrophage accumulation in adipose tissue is a known feature of obesity, where it is linked with increasing insulin resistance. However, the characteristics of adipose tissue macrophage accumulation in critical illness remain unknown. METHODS: We studied macrophage markers with immunostaining and gene expression in visceral and subcutaneous adipose tissue from healthy control subjects (n = 20) and non-surviving prolonged critically ill patients (n = 61). For comparison, also subcutaneous in vivo adipose tissue biopsies were studied from 15 prolonged critically ill patients. RESULTS: Subcutaneous and visceral adipose tissue biopsies from non-surviving prolonged critically ill patients displayed a large increase in macrophage staining. This staining corresponded with elevated gene expression of "alternatively activated" M2 macrophage markers arginase-1, IL-10 and CD163 and low levels of the "classically activated" M1 macrophage markers tumor necrosis factor (TNF)-α and inducible nitric-oxide synthase (iNOS). Immunostaining for CD163 confirmed positive M2 macrophage staining in both visceral and subcutaneous adipose tissue biopsies from critically ill patients. Surprisingly, circulating levels and tissue gene expression of the alternative M2 activators IL-4 and IL-13 were low and not different from controls. In contrast, adipose tissue protein levels of peroxisome proliferator-activated receptor-γ (PPARγ), a nuclear receptor required for M2 differentiation and acting downstream of IL-4, was markedly elevated in illness. In subcutaneous abdominal adipose tissue biopsies from surviving critically ill patients, we could confirm positive macrophage staining with CD68 and CD163. We also could confirm elevated arginase-1 gene expression and elevated PPARγ protein levels. CONCLUSIONS: Unlike obesity, critical illness evokes adipose tissue accumulation of alternatively activated M2 macrophages, which have local anti-inflammatory and insulin sensitizing features. This M2 macrophage accumulation may contribute to the previously observed protective metabolic activity of adipose tissue during critical illness.
format Online
Article
Text
id pubmed-3334796
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33347962012-04-25 Critical illness induces alternative activation of M2 macrophages in adipose tissue Langouche, Lies Marques, Mirna B Ingels, Catherine Gunst, Jan Derde, Sarah Vander Perre, Sarah D'Hoore, André Van den Berghe, Greet Crit Care Research INTRODUCTION: We recently reported macrophage accumulation in adipose tissue of critically ill patients. Classically activated macrophage accumulation in adipose tissue is a known feature of obesity, where it is linked with increasing insulin resistance. However, the characteristics of adipose tissue macrophage accumulation in critical illness remain unknown. METHODS: We studied macrophage markers with immunostaining and gene expression in visceral and subcutaneous adipose tissue from healthy control subjects (n = 20) and non-surviving prolonged critically ill patients (n = 61). For comparison, also subcutaneous in vivo adipose tissue biopsies were studied from 15 prolonged critically ill patients. RESULTS: Subcutaneous and visceral adipose tissue biopsies from non-surviving prolonged critically ill patients displayed a large increase in macrophage staining. This staining corresponded with elevated gene expression of "alternatively activated" M2 macrophage markers arginase-1, IL-10 and CD163 and low levels of the "classically activated" M1 macrophage markers tumor necrosis factor (TNF)-α and inducible nitric-oxide synthase (iNOS). Immunostaining for CD163 confirmed positive M2 macrophage staining in both visceral and subcutaneous adipose tissue biopsies from critically ill patients. Surprisingly, circulating levels and tissue gene expression of the alternative M2 activators IL-4 and IL-13 were low and not different from controls. In contrast, adipose tissue protein levels of peroxisome proliferator-activated receptor-γ (PPARγ), a nuclear receptor required for M2 differentiation and acting downstream of IL-4, was markedly elevated in illness. In subcutaneous abdominal adipose tissue biopsies from surviving critically ill patients, we could confirm positive macrophage staining with CD68 and CD163. We also could confirm elevated arginase-1 gene expression and elevated PPARγ protein levels. CONCLUSIONS: Unlike obesity, critical illness evokes adipose tissue accumulation of alternatively activated M2 macrophages, which have local anti-inflammatory and insulin sensitizing features. This M2 macrophage accumulation may contribute to the previously observed protective metabolic activity of adipose tissue during critical illness. BioMed Central 2011 2011-10-21 /pmc/articles/PMC3334796/ /pubmed/22018099 http://dx.doi.org/10.1186/cc10503 Text en Copyright ©2011 Langouche et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Langouche, Lies
Marques, Mirna B
Ingels, Catherine
Gunst, Jan
Derde, Sarah
Vander Perre, Sarah
D'Hoore, André
Van den Berghe, Greet
Critical illness induces alternative activation of M2 macrophages in adipose tissue
title Critical illness induces alternative activation of M2 macrophages in adipose tissue
title_full Critical illness induces alternative activation of M2 macrophages in adipose tissue
title_fullStr Critical illness induces alternative activation of M2 macrophages in adipose tissue
title_full_unstemmed Critical illness induces alternative activation of M2 macrophages in adipose tissue
title_short Critical illness induces alternative activation of M2 macrophages in adipose tissue
title_sort critical illness induces alternative activation of m2 macrophages in adipose tissue
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334796/
https://www.ncbi.nlm.nih.gov/pubmed/22018099
http://dx.doi.org/10.1186/cc10503
work_keys_str_mv AT langouchelies criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT marquesmirnab criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT ingelscatherine criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT gunstjan criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT derdesarah criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT vanderperresarah criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT dhooreandre criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue
AT vandenberghegreet criticalillnessinducesalternativeactivationofm2macrophagesinadiposetissue